awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47622968-B1F4463E-5B09-4114-AD51-094C9E5D0BBD
Q47622968-B1F4463E-5B09-4114-AD51-094C9E5D0BBD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47622968-B1F4463E-5B09-4114-AD51-094C9E5D0BBD
ATR/CHK1 inhibitors and cancer therapy.
P2860
Q47622968-B1F4463E-5B09-4114-AD51-094C9E5D0BBD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47622968-B1F4463E-5B09-4114-AD51-094C9E5D0BBD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4d392ed64ff5a2ef7fe8d25f3a0d5144184b2b17
P2860
Preclinical analyses and phase I evaluation of LY2603618 administered in combination with pemetrexed and cisplatin in patients with advanced cancer.